MDB PHARMA CONSULTING: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MDB PHARMA CONSULTING
Largest movements
- Cash -€32,927
down €32,927 (-17.7%), from €186,235 to €153,308
mainly Other debts (-€32,841) and Receivables within one year (-€10,623)
- Receivables within one year +€10,623
up €10,623 (+107%), from €9,958 to €20,580
of which Trade receivables: +€7,076
- Current investments -€3,298
down €3,298 (-8.6%), from €38,504 to €35,206
- Other debts -€32,841
down €32,841 (-86.4%), from €38,022 to €5,181
- Reserves +€12,000
up €12,000 (+6.8%), from €175,860 to €187,860
of which Distributable reserves: +€12,000
- Tax, wage and social debts -€7,068
down €7,068 (-61.8%), from €11,441 to €4,373
- Gross operating margin -€25,931
down €25,931 (-55.2%), from €47,007 to €21,077
- Taxes -€8,242
down €8,242 (-54.3%), from €15,182 to €6,940
- Depreciation +€784
up €784 (+60.5%), from €1,296 to €2,080
- Financial income +€546
up €546 (+69.1%), from €790 to €1,336
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €240,183 | €212,538 | -€27,645 | -11.5% |
| Fixed assets | 21/28 | €4,945 | €2,865 | -€2,080 | -42.1% |
| Tangible fixed assets | 22/27 | €4,945 | €2,865 | -€2,080 | -42.1% |
| Furniture and vehicles | 24 | €4,945 | €2,865 | -€2,080 | -42.1% |
| Current assets | 29/58 | €235,238 | €209,673 | -€25,565 | -10.9% |
| Amounts receivable within one year | 40/41 | €9,958 | €20,580 | +€10,623 | +107% |
| Trade receivables | 40 | €7,006 | €14,082 | +€7,076 | +101% |
| Other amounts receivable | 41 | €2,952 | €6,499 | +€3,546 | +120% |
| Current investments | 50/53 | €38,504 | €35,206 | -€3,298 | -8.6% |
| Cash at bank and in hand | 54/58 | €186,235 | €153,308 | -€32,927 | -17.7% |
| Deferred charges and accrued income | 490/1 | €541 | €578 | +€37 | +6.9% |
| Total equity and liabilities | 10/49 | €240,183 | €212,538 | -€27,645 | -11.5% |
| Equity | 10/15 | €189,407 | €200,936 | +€11,529 | +6.1% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €175,860 | €187,860 | +€12,000 | +6.8% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €174,000 | €186,000 | +€12,000 | +6.9% |
| Profit (loss) carried forward | 14 | €1,147 | €676 | -€471 | -41.0% |
| Amounts payable | 17/49 | €50,775 | €11,601 | -€39,174 | -77.2% |
| Amounts payable within one year | 42/48 | €50,775 | €11,601 | -€39,174 | -77.2% |
| Trade debts | 44 | €1,312 | €2,048 | +€736 | +56.1% |
| Suppliers | 440/4 | €1,312 | €2,048 | +€736 | +56.1% |
| Taxes, remuneration and social security | 45 | €11,441 | €4,373 | -€7,068 | -61.8% |
| Taxes | 450/3 | €11,441 | €4,373 | -€7,068 | -61.8% |
| Other amounts payable | 47/48 | €38,022 | €5,181 | -€32,841 | -86.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,296 | €2,080 | +€784 | +60.5% |
| Other operating charges | 640/8 | €560 | €400 | -€161 | -28.7% |
| Gross operating margin | 9900 | €47,007 | €21,077 | -€25,931 | -55.2% |
| Operating profit (loss) | 9901 | €45,151 | €18,597 | -€26,554 | -58.8% |
| Financial income | 75/76B | €790 | €1,336 | +€546 | +69.1% |
| Recurring financial income | 75 | €790 | €1,336 | +€546 | +69.1% |
| Financial charges | 65/66B | €644 | €632 | -€12 | -1.9% |
| Recurring financial charges | 65 | €644 | €632 | -€12 | -1.9% |
| Profit (loss) for the period before taxes | 9903 | €45,298 | €19,301 | -€25,996 | -57.4% |
| Income taxes | 67/77 | €15,182 | €6,940 | -€8,242 | -54.3% |
| Profit (loss) for the period | 9904 | €30,116 | €12,362 | -€17,754 | -59.0% |
| Profit (loss) for the period to be appropriated | 9905 | €30,116 | €12,362 | -€17,754 | -59.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.